Drugs-Forum  
Home Wiki Studies Forum Groups Blog Video Images News
Go Back   Drugs Forum > RECOVERY & ADDICTION > Drug Addiction & Recovery > Cannabis addiction
Mark Forums Read
Register Tags

Notices

Cannabis addiction Support for coping with Cannabinoid & Cannabis dependence.

 
Thread Tools
  #1  
Old 10-02-2011, 21:47
Shampoo Shampoo is offline
entity of sorts
Moderator
 
Join Date: 10-11-2007
Male from United States
Posts: 2,413
Blog Entries: 2
Shampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond repute
Points: 7,788, Level: 12 Points: 7,788, Level: 12 Points: 7,788, Level: 12
Activity: 8.3% Activity: 8.3% Activity: 8.3%
Mediating Cannabis Withdrawal Symptoms via Endocannabinoid Modulation

Mediating Cannabis/Cannabinoid Withdrawal Symptoms via Endocannabinoid Modulation
A theory and case study


Cannabis/Cannabinoid withdrawal is a notable syndrome in frequent, heavy users of Cannabis or synthetic Cannabinoid receptor agonists (Lichtman, 2002). Investigating the functional consequences of the effects of withdrawal has been a significant focus of research over the past decade (Budney et al., 2004; Haughey, 2008). A better understanding of these mechanisms may allow for therapeutic treatment, as outlined within this discussion and caste-study. Withdrawal symptoms precipitated from the cessation of Cannabis or Cannabinoid consumption are largely mediated by upregulation and sensitization of CBRs (in particular, the presynaptic CB1R) (Aceto, 1995). Modulation of the eCB system may prove a viable mechanism for mediating the physiological and psychological effects of this receptor regulation/sensitization. Several routes towards eCB modulation are outlined and the efficacy of their in vivo effects remain in question. A single case-study suggests that the symptoms of cessation-induced withdrawal may be abolished by eCB modulation, though further study is required to generalize the data to a broad population.


Abbreviations
2-AG - 2-Arachidonoylglycerol
AEA - Anandamide (N-arachidonoylethanolamine)
BBB- Blood Brain Barrier
CBR - Cannabinoid Receptor
CB1R - Cannabinoid Receptor 1
eCB - Endocannabinoid
FAAH - Fatty Acid Amide Hydrolase
MAGL - Monoacylglycerol Lipase
NAPE - N-arachidonoyl phosphatidylethanolamine


Theory: Increasing basal levels of eCBs

One route to increasing basal levels of eCBs (AEA, 2-AG..etc.) is inhibiting their uptake and degradation, while another is supplementing the necessary precursors required for their synthesis and release. A number of approaches in both of these directions may be effective; a cursory review of which are provided here.

The primary eCB, AEA, is largely degraded in vivo by FAAH, a process which results in the production of ethanolamine and arachidonic acid (Di Marzo, 2008). Inhibitors of FAAH will lead to increased levels of AEA at the synapse, resulting in increased occupancy of presynaptic CB1Rs (Williams & Kirkham, 1999; Hwang, 2009). One known inhibitor of FAAH is AM-404 (N-(4-hydroxyphenyl)arachidonoylethanolamide), an active metabolite of paracematol (acetaminophen) which readily crosses the BBB (Kumpulainen, 2007). N-oleoylethanolamine and N-linoleoylethanolamine are also inhibitors of FAAH, both of which are found in chocolate. In other words, supplementation with paracematol and chocolate may both increase basal concentrations of AEA. Additionally, chocolate contains AEA itself, which has been shown to readily cross the BBB. Finally, Biochanin A, an isoflavanone, has been shown to be an effective peripheral inhibitor of FAAH (Thors et al., 2010) and is readily found in a number of dietary sources, including red clover, soy beans and peanuts. Peripheral inhibition of FAAH may help to mediate some physiological symptoms of Cannabis/Cannabinoid withdrawal, including gastric discomfort and increased nociceptive sensitivity.

In regards to the other major CB1R agonist eCB, 2-AG, much of the above applies, as FAAH is responsible for at least some component of 2-AG metabolism. The remaining metabolism of 2-AG is mediated by MAGL (by some reports, this may be the primary metabolic enzyme involved in 2-AG degradation) (Di Marzo, 2008). Though inhibitors of MAGL are not nearly as readily available as FAAH inhibitors, JZL184 has been shown to elevate 2-AG levels in vivo (Long et al., 2008), but for the time being this remains a research tool, not for human consumption. Elevating 2-AG levels may be best accomplished via FAAH inhibitors as described above.

It should be noted that, unlike most neurotransmitters, eCBs are synthesized on-demand, so simply inhibiting their degradation will not necessarily have the desired effect. There are a number of means of increasing the synthesis of eCBs, namely exercise* (Sparling, 2003; Dietrich, 2004). A number of studies have shown that prolonged physical exertion results in the increase synthesis and release of the eCBs AEA and 2-AG. In combination with an FAAH inhibitor, exercise may produce prolonged increases in the synaptic concentrations of these eCBs.

Additionally, supplementing one's diet with the precursors and co-enzymes necessary for the synthesis of these eCBs may prove to be an additionally effective means for increasing eCB levels. Some notable supplements in this regard are arachidonic acid, glycerol, and NAPE. Arachidonic acid is an omega-6 fatty acid and may be found in a number of OTC supplements, as well as naturally occurring in a number of ingestible animal products, including meat, eggs, and some dairy. Glycerol is a sugar-substitute and may be found from many culinary sources. NAPE is also found as a supplement and despite some purported psychoactivity (debatable), is not controlled or scheduled in any manner. Acetyl-CoA is the only readily bioavailable coenzyme in the synthesis of eCBs, and may be supplemented in the diet by pantothenic acid (vitamin B5).

In conclusion, one might find themselves fit to inhibit the development of certain forms of Cannabis/Cannabinoid withdrawal by a combination of precursor/coenzyme supplementation, degradation inhibition and exercise-induced eCB synthesis. A diet with supplements of arachidonic acid, glycerol, chocolate, and/or NAPE, as well as pantothenic acid, in addition to regular exercise and the use of FAAH inhibitors such as paracemtol/AM-404 (or, again, chocolate) should suffice to account for these factors.

*Note -- Exercise also has been shown to increase endogenous production of endogenous opioids. Considering the relationship between Cannabinoid withdrawals and opioid receptor activation/regulation, this may be another mechanism by which exercise may inhibit the expression of certain forms of cannabinoid withdrawal.


In practice: A case-study
Quote:
Subject data

Age: 23
Weight: 145lb
Height: 5' 7"
BMI: 22.7
Current supplements/medication: GliSODin (100mg, daily in weekly on/off cycles), Alpha-GPC (250mg, daily), Omega 3-6-9 (600mg, daily), multivitamin (3-4x/week), Melatonin (500µg, 3-4x/week), Phenibut (1-2x/week)*, Zolpidem tartate (5mg, 1-2x/week)*
Additional notes: Subject is well-educated (B.S., M.S., PhD Candidacy), actively monitors a vegetarian diet, in excellent physical condition (average resting heart-rate [HRrest] is 54 BPM) and of relatively healthy mental status (diagnosed major depressive disorder, no incidence of significant clinical depression in 6mo.).

*Phenibut & Zolpidem use were temporarily discontinued 3 weeks prior to trial initiation with no significant withdrawal or side-effects.

Subject Cannabis/Cannabinoid use history: The subject was a regular consumer of Cannabis from age 16-23, ingesting ~500-1,000mg of high-quality (18%+ THC) Cannabis daily from age 19-23 with intermittent 5-6 day cessation periods occurring 1-3x/year. Previous use was regular but not daily (~4-5x/week). Over the past 18 months, the subject has intermittently experimented with synthetic cannabinoid agonists (orally, transdermally and through vaporization [rarely]) not limited to but including CP-47,497/55,940, HU-210, JWH-007/015/018/019/073/081/133/200/210/250, WIN 55,212-2. The subject has not previously noted significant side-effects from regular usage, though suffers withdrawal symptoms upon cessation which include an increase in HRrest and blood-pressure, increased irritability and generalized anxiety, difficulty in initiating and maintaining proper sleep, poor mood and motivation, increased sensitivity to painful stimuli, gastric discomfort with decreased frequency of bowl movements, severely decreased appetite and increased incidence of both conscious and unconscious (sleeping) bruxism.

Study: The subject ceased all Cannabis/Cannabinoid consumption without tapering from the above average doses (500-1,000mg/day, Cannabis). Immediately the subject began supplementing with 3-4oz 78% chocolate spread intermittently throughout the day, 50mg Safflower-oil NAPE 1x/day in the morning, along with additional 5mg pantothenic acid, 1200mg Omega 3-6-9 complex. The subject also began using a mild glycerol extract in place of sucrose in his morning coffee. With each meal, the subject ingests 500mg paracematol. In addition to the subject's regular exercise regimen (90min cardiovascular oriented cycling 3x/week, 60min strength training 2x/week), a 60min cardiovascular exercise (running) was incorporated into the subject's routine on the 2 previously-designated "off-days."

After 10 days, the subject reported absolutely no withdrawal symptoms. Appetite was maintained at standard levels, no anxiety/irritability was reported, sleep patterns noted as regular (100-110min REM/night, as monitored by EEG), no incidence of bruxism, sensitivity to painful stimuli, or change in frequency of bowel movements. A mild increase in HRrest (∆+5-7BPM for days 1-6 post-cessation, +/-0BPM thereafter) was noted with no change in mean blood-pressure.

On day 10, the subject ceased consumption of NAPE-isolate and reduced paracematol to 1x/day with no notable change in effect. On day 15 the subject ceased consumption of additional Omega 3-6-9 complex, glycerol, paracematol and pantothenic acid supplementation with no notable change in effect. On day 17 the subject resumed normal exercise routine by returning to two "off-days" with no notable effect. The study ended on day 30 with the subject reporting normal behavior, no notable side-effects from withdrawal, no notable cravings to re-administer Cannabis/Cannabinoids even when probed with multiple cues (the presence of smoke, the aroma of fresh Cannabis, and the tactile handling of glassware used for Cannabis consumption). A follow-up study on day 60 reports no change. Compliance with cessation was monitored by self-report.

Conclusions: The above study suggests that a chemical and physical supplementation diet may act to prevent the development of Cannabis/Cannabinoid-mediated withdrawal symptoms in some subjects. Further study is required to generalize to a larger population. The individual contributions of each element are debatable, and future studies with isolated or combined supplementation are required to further define the effects of the regimen on abolishing Cannabis/Cannabinoid-mediated withdrawal.
Resources

Aceto, M. "Cannabinoid Precipitated Withdrawal by the Selective Cannabinoid Receptor Antagonist, SR 141716A." European Journal of Pharmacology 282.1-3 (1995): R1-R2.

Budney, Alan J., Hughes, J.R., Moore, B.A., & Vandrey, R. (2004, November). Review of the Validity and Significance of Cannabis Withdrawal Syndrome. American Journal of Psychiatry, 161, 1967-1977.

Di Marzo, V. "Endocannabinoids: Synthesis and Degradation." Rev Physiol Biochem Pharmacol 160 (2008): 1-24.

Dietrich, A. "Endocannabinoids and Exercise." British Journal of Sports Medicine 38.5 (2004): 536-41.

Haughey, Heather M., Erin Marshall, Joseph P. Schacht, Ashleigh Louis, and Kent E. Hutchison. "Marijuana Withdrawal and Craving: Influence of the Cannabinoid Receptor 1 () and Fatty Acid Amide Hydrolase () Genes." Addiction 103.10 (2008): 1678-686.

Hwang, Jeannie, Crista Adamson, David Butler, David R. Janero, Alexandros Makriyannis, and Ben A. Bahr. "Enhancement of Endocannabinoid Signaling by Fatty Acid Amide Hydrolase Inhibition: A Neuroprotective Therapeutic Modality." Life Sciences (2009).

Kumpulainen, E., H. Kokki, T. Halonen, M. Heikkinen, J. Savolainen, and M. Laisalmi. "Paracetamol (Acetaminophen) Penetrates Readily Into the Cerebrospinal Fluid of Children After Intravenous Administration." Pediatrics 119.4 (2007): 766-71.

Lichtman, A. H., and B. R. Martin. "Marijuana Withdrawal Syndrome in the Animal Model." J Clin Pharmacol 42 (2002): 20S-7S.

Sparling, P. B., A. Giuffrida, D. Piomelli, L. Rosskopf, and A. Dietrich. "Exercise Activates the Endocannabinoid System." NeuroReport 14.17 (2003): 2209-211.

Thors, L., J. J. Burston, B. J. Alter, M. K. McKinney, B. F. Cravatt, Robert A. Ross, R. G. Pertwee, R. W. Gereau 4th, J. L. Wiley, and C. J. Fowler. "Biochanin A, a Naturally Occurring Inhibitor of Fatty Acid Amide Hydrolase." Br J Pharmacol 160.3 (2010): 549-60.

Williams, Claire M., and T. C. Kirkham. "Anandamide Induces Overeating: Mediation by Central Cannabinoid (CB1) Receptors." Psychopharmacology 143.3 (1999): 315-17.


Post Quality Evaluations:
Well researched verifiability for sure, Very useful information, Really adds value to the community at large
well thought out experiment, fascinating topic, one that deserves much more publicity
good information provided here; Ty for sharing.

Last edited by Shampoo; 11-02-2011 at 03:07.
  #2  
Old 13-02-2011, 04:08
iheartbonsai iheartbonsai is offline
Account Awaiting Email Confirmation.
 
Join Date: 17-01-2011
40 y/o Female from Earth
Posts: 17
iheartbonsai is an unknown quantity at this point
Points: 27, Level: 1 Points: 27, Level: 1 Points: 27, Level: 1
Activity: 0% Activity: 0% Activity: 0%
Re: Mediating Cannabis Withdrawal Symptoms via Endocannabinoid Modulation

This is a great post!

I think this information will be very useful for someone experiencing withdrawal symptoms.


Do you think JZL184 inhibition factor is actually irreversible?

If so, do you think would that mean that after application one would experience more CB activity than others if cannabinoids are applied?

Could it be that the lab rats will be somewhat stoned for the rest of their lives? Never sober again from just one application?

Very interesting indeed.

Again thanks for the high quality post!

Definitely got me thinking





Post Quality Evaluations:
Please don't format your posts like this. It's hard to read.

Last edited by iheartbonsai; 13-02-2011 at 04:15. Reason: editing font color
  #3  
Old 13-02-2011, 19:30
Shampoo Shampoo is offline
entity of sorts
Moderator
 
Join Date: 10-11-2007
Male from United States
Posts: 2,413
Blog Entries: 2
Shampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond repute
Points: 7,788, Level: 12 Points: 7,788, Level: 12 Points: 7,788, Level: 12
Activity: 8.3% Activity: 8.3% Activity: 8.3%
Re: Mediating Cannabis Withdrawal Symptoms via Endocannabinoid Modulation

Quote:
Originally Posted by iheartbonsai View Post



Do you think JZL184 inhibition factor is actually irreversible?
Yes, but to understand the implication of that you must understand the nature of protein/enzyme turnover in human biology. JZL184 irreversibly inhibits MAGL, but the specific MAGL that you have at this moment is undergoing regular synthesis and degradation, down and up-regulation. The body is far from static.

Quote:
If so, do you think would that mean that after application one would experience more CB activity than others if cannabinoids are applied?
Possibly, but only for the active life of the compound.

Quote:
Could it be that the lab rats will be somewhat stoned for the rest of their lives? Never sober again from just one application?
No.

As an example, paracemetol (acetaminophen) is an irreversible COX inhibitor-- does a single dose of paracemetol have permanent NSAID effects?

From the discussion of Long et al., 2009:
Quote:
The increased brain levels of 2-AG induced by a single dose of JZL184 were maintained for a remarkable period of time (≥ 8 h), likely reflecting the relatively long half-life of this inhibitor in vivo (~7 h; see Supplementary Fig. 8 online). It is notable, however, that brain 2-AG levels returned to baseline by 24 h post-treatment with JZL184, even though MAGL remained mostly inactive at this time point. These results might indicate a homeostatic feedback mechanism that operates to rectify heightened 2-AG concentrations in the nervous system.

Last edited by Shampoo; 13-02-2011 at 19:37.
  #4  
Old 14-02-2011, 21:10
iheartbonsai iheartbonsai is offline
Account Awaiting Email Confirmation.
 
Join Date: 17-01-2011
40 y/o Female from Earth
Posts: 17
iheartbonsai is an unknown quantity at this point
Points: 27, Level: 1 Points: 27, Level: 1 Points: 27, Level: 1
Activity: 0% Activity: 0% Activity: 0%
Re: Mediating Cannabis Withdrawal Symptoms via Endocannabinoid Modulation

Thanks for clearing that up! I don’t know chemistry that well but I'm learning.

Just saw the reputation comment thanks for the tip and neutral status.

Like with chemistry; still have some learning to do! So I really do appreciate your understanding. Constructive feedback is always welcomed.

Last edited by iheartbonsai; 15-02-2011 at 07:53. Reason: added a comment about rep received
  #5  
Old 22-02-2011, 17:08
nate81 nate81 is offline
Titanium Member
 
Join Date: 16-10-2007
32 y/o Male from USA - Missouri
Posts: 432
nate81 probably knows what they are talking about.nate81 probably knows what they are talking about.nate81 probably knows what they are talking about.nate81 probably knows what they are talking about.nate81 probably knows what they are talking about.
Points: 256, Level: 2 Points: 256, Level: 2 Points: 256, Level: 2
Activity: 0.4% Activity: 0.4% Activity: 0.4%
Re: Mediating Cannabis Withdrawal Symptoms via Endocannabinoid Modulation

I loved this Shampoo. Alfrendo will use this knowledge himself. He had read but forgotten that endogenous cannabinoids were released with exercise. Just so people are aware, "prolonged exercise" that releases cannabinoids typically means an hour of exercise at 70-80% of your maximum heart rate. A bit of dark chocolate right before and right after exercise will catch those eCB's nicely.
  #6  
Old 06-03-2011, 18:13
FreeBliss FreeBliss is offline
Silver Member
 
Join Date: 26-01-2010
26 y/o Male from United States
Posts: 369
FreeBliss is a decent psychonaut.FreeBliss is a decent psychonaut.
Points: 47, Level: 1 Points: 47, Level: 1 Points: 47, Level: 1
Activity: 1.1% Activity: 1.1% Activity: 1.1%
Re: Mediating Cannabis Withdrawal Symptoms via Endocannabinoid Modulation

definatly give your self the precursors. please god dont give any ideas for cb reuptake inhibitors. someone would love to patent a new crazy drug.

animide or whatever i thinks converted from omega 3's. sorry i just seen u say omega 6 was the one. i will have to look that up. hemp seed oil contains them all 3,6,and9.

Last edited by FreeBliss; 06-03-2011 at 18:21.
  #7  
Old 06-03-2011, 22:35
Shampoo Shampoo is offline
entity of sorts
Moderator
 
Join Date: 10-11-2007
Male from United States
Posts: 2,413
Blog Entries: 2
Shampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond reputeShampoo is a true resource and beyond repute
Points: 7,788, Level: 12 Points: 7,788, Level: 12 Points: 7,788, Level: 12
Activity: 8.3% Activity: 8.3% Activity: 8.3%
Re: Mediating Cannabis Withdrawal Symptoms via Endocannabinoid Modulation

Quote:
Originally Posted by FreeBliss View Post
definatly give your self the precursors.
Right. Did you get a chance to read the thread before replying?
Quote:
Originally Posted by Shampoo
Additionally, supplementing one's diet with the precursors and co-enzymes necessary for the synthesis of these eCBs may prove to be an additionally effective means for increasing eCB levels. Some notable supplements in this regard are arachidonic acid, glycerol, and NAPE. Arachidonic acid is an omega-6 fatty acid and may be found in a number of OTC supplements, as well as naturally occurring in a number of ingestible animal products, including meat, eggs, and some dairy. Glycerol is a sugar-substitute and may be found from many culinary sources. NAPE is also found as a supplement and despite some purported psychoactivity (debatable), is not controlled or scheduled in any manner. Acetyl-CoA is the only readily bioavailable coenzyme in the synthesis of eCBs, and may be supplemented in the diet by pantothenic acid (vitamin B5).
Quote:
Originally Posted by FreeBliss View Post
please god dont give any ideas for cb reuptake inhibitors. someone would love to patent a new crazy drug.
The eCB system does necessarily not work this way. There is serious debate as to the existence of an eCB transport protein. eCBs are synthesized on-demand, and are a retrograde neurotransmitter (i.e. they are released by the post-synaptic neuron and act on the presynaptic neuron). eCBs are then degraded by FAAH (post-synaptically) or MAGL (presynaptically) (also, included in the first post..). FAAH inhibition is the route to inhibiting enzymatic degradation. MAGL inhibition is another possibility (see... the first post). As for the concept of a "crazy drug," the eCB system is a major target of pharmaceutical development, and a number of enzyme inhibitors are currently being investigated for pharmaceutical effects; there does not appear to be much psychoactivity involved (i.e. an FAAH or MAGL inhibitor does not get you "high").

Last edited by Shampoo; 06-07-2011 at 00:52.
  #8  
Old 25-03-2011, 15:37
NeuroChi NeuroChi is offline
is not his mind
 
Join Date: 18-12-2007
Male from Earth
Posts: 4,631
Blog Entries: 5
NeuroChi is a true resource and beyond reputeNeuroChi is a true resource and beyond reputeNeuroChi is a true resource and beyond reputeNeuroChi is a true resource and beyond reputeNeuroChi is a true resource and beyond reputeNeuroChi is a true resource and beyond reputeNeuroChi is a true resource and beyond reputeNeuroChi is a true resource and beyond reputeNeuroChi is a true resource and beyond reputeNeuroChi is a true resource and beyond reputeNeuroChi is a true resource and beyond repute
Points: 21,116, Level: 21 Points: 21,116, Level: 21 Points: 21,116, Level: 21
Activity: 9.2% Activity: 9.2% Activity: 9.2%
Re: Mediating Cannabis Withdrawal Symptoms via Endocannabinoid Modulation

Quote:
Originally Posted by Shampoo View Post
The eCB system does not work this way. There is not an eCB reuptake protein. eCBs are synthesized on-demand, and are a retrograde neurotransmitter (i.e. they are released by the post-synaptic neuron and act on the presynaptic neuron).
To clarify slightly further: "on-demand" refers to their synthesis and release only when it is appropriate for the post-synaptic neuron to do. This occurs when the pre-synaptic neuron is releasing higher than baseline levels of Glutamate and accumulation of Calcium occurs in the post synaptic neuron. It is possible that the reason that FAAH or MAGL inhibitors do not have psychoactive effect is that they would only increase eCB levels where eCB's are present, which surely isn't in every neuron throughout the entire brain (at a given time). Administering exogenous cannabinoids systemically results in a wholesome distribution of cannabinoids at every* synapse, hijakcing the system in such a way that would theoretically be impossible with eCB inhibitors.
  #9  
Old 25-02-2013, 01:23
bufalantan bufalantan is offline
Silver Member
 
Join Date: 12-05-2010
45 y/o Male from Isle of Man
Posts: 96
bufalantan is learning how to become a psychonaut.
Points: 146, Level: 1 Points: 146, Level: 1 Points: 146, Level: 1
Activity: 0.9% Activity: 0.9% Activity: 0.9%
Re: Mediating Cannabis Withdrawal Symptoms via Endocannabinoid Modulation

Quote:
Originally Posted by Shampoo View Post
[CENTER]Mediating Cannabis/Cannabinoid Withdrawal Symptoms via Endocannabinoid Modulation
A theory and case study


Cannabis/Cannabinoid withdrawal is a notable syndrome in
Sorry shampoo, but how is it mediating Cannabinoid withdrawal via Endocannabinoid Modulation , if a cannabinoid like am-404 was used?


Some would suggest co administration of alpha lipoic acid with Omega 3, at 1:2 ratio, first thing in the morning and the same for bed time with the addition of l-tryptophan (5ht, 5htp, etc).

Example: 100 mg Lipoic acid, 200 mg Omega 3 (falxseed oil) first thing in the morning (maybe again in the after noon if needed) and with l-tryptophan before bed. Loads of Chocolates in between, bananas, and some thing with vitamins and fibers per your gastric condition. Hydrate and get something to focus on for like 4 days.

The above was for am-404 free withdrawl. If OTC drugs are an option, the same people that suggested the above would recommend notroopics for a week.

Non addictive personalities, benzos might be the fastest solution, but of course with an Rx from a professional etc.

Last edited by bufalantan; 27-02-2013 at 23:03. Reason: Additional comment.

Share this on:

Tags
over the counter drug, thc, withdrawals

Thread Tools


Similar Threads
Thread Thread Starter Forum Replies Last Post
Longitudinal Teen Study: First Puff-->Daily Use. Factors Involved in Daily MJ Use Richard_smoker Miscellaneous News 13 05-08-2013 16:07
Does cannabis use lead to mental-health problems?: findings from the research Lunar Loops Cannabis & Health 33 17-06-2013 07:40
Cannabis Shampoo Drug Articles 28 02-05-2012 13:38
Drug info - Chemical ecology of Cannabis Sitbcknchill Cannabis 4 28-04-2009 03:00

» New Threads
Concerned for friend's children...
Last post by Iggypants
2 Replies, 24 Views
come up different in rock form vs....
Last post by elperuano
6 Replies, 126 Views
Ur-144 oral consumption
Last post by nextgeneye
5 Replies, 2,997 Views
Helping my son through withdrawal...
Last post by gmeziscool2354
8 Replies, 196 Views
Over dose or over did it?...
Last post by inbdid30
5 Replies, 173 Views
moist meth
Last post by LateNightZombie
5 Replies, 168 Views
Need help with...
Last post by Sweeny
14 Replies, 304 Views
Opiate and benzos withdrawal...
Last post by Dawn Godess
22 Replies, 1,124 Views
More likely to get blitzed when...
Last post by Calyann
3 Replies, 72 Views
Kratom Combinations
Last post by Elizorz
136 Replies, 63,607 Views
» New Wiki Articles

Sitelinks: Information:

All times are GMT +1. The time now is 20:41.


Copyright: SIN Foundation 2003 - 2014, All rights reserved
"Wiki" powered by VaultWiki v3.0.20 PL 1.